Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...

Berlin: Bayer has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products ...

Age-related macular degeneration (AMD) is a progressive eye disease where the macula – the part of the retina responsible for central vision – ...

A new study shows that tiny gold particles could circumvent damaged photoreceptors in patients with macular degeneration and ...

According to the German Ophthalmological Society (DOG), over 1.5 million eye surgeries are performed annually in the country, ...

Berlin: Bayer has submitted an application to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval of ...

Symptoms suggestive of post-injection endophthalmitis or retinal detachment require ... physicians about best practices in the treatment of age-related macular degeneration (AMD).

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

Ashvattha Therapeutics reveals promising phase 2 results for migaldendranib, showcasing significant improvements in retinal disease treatment and reduced injection burden.

Dry age-related macular degeneration ... advancement in the treatment of AMD, designed to reduce the need for frequent intravitreal injections by enabling the eye’s own cells to produce ...

This is a significant move to elevate the standard of care for various eye conditions like Diabetic Macular Edema (DME) and ...